- Country: Norway
- Summary: Enhanced Quadrivalent Vaccine against Seasonal Influenza for the 2024-2025 Season
- NOT Ref No: 94073996
- Deadline: 01 Feb 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 23/04212
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Enhanced quadrivalent vaccine against seasonal influenza for the season 2024-2025
Process :-1.4 Open tender above EEA threshold value (one step)
Type de contrat :-Supplies
CPV codes :-33651660-2 Influenza vaccines
Des pays : Norway
Derniere date de soumission : 01/02/2024 13:00:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEnhanced Quadrivalent Vaccine against Seasonal Influenza for the 2024-2025 Season - Norway Tender
The THE INSTITUTE OF PUBLIC HEALTH, a Government sector organization in Norway, has announced a new tender for Enhanced Quadrivalent Vaccine against Seasonal Influenza for the 2024-2025 Season. This tender is published on NorwayTenders under NOT Ref No: 94073996 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-02-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
